REGIONAL HEALTH PROPERTIES, INC (RHEPZ)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue TTM

0 30M 60M 90M Q3 '21: 24M Q4 '21: 26.7M Q1 '22: 26.3M Q2 '22: 27.9M Q3 '22: 32.2M Q4 '22: 35.9M Q1 '23: 33.2M Q2 '23: 29.7M Q3 '23: 22.8M Q4 '23: 17.2M Q1 '24: 17.4M Q2 '24: 17.1M Q3 '24: 17.2M Q4 '24: 18.3M Q1 '25: 21.4M Q2 '25: 27.1M Q3 '25: 38M Q4 '25: 53.2M Q1 '26: 67.1M Q2 '26: 81.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit TTM

0 25M 50M 75M Q2 '26: 64M Q2 '26

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income TTM

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '20: 3.8M Q4 '21: 2.5M Q1 '22: 92K Q2 '22: -923K Q3 '22: -3.5M Q4 '22: -6.8M Q1 '23: -6.2M Q2 '23: -5.5M Q3 '23: -3.9M Q4 '23: -821K Q1 '24: -353K Q2 '24: -325K Q3 '24: -221K Q4 '24: 161K Q1 '25: 137K Q2 '25: -585K Q3 '25: -879K Q4 '25: 1.7M Q1 '26: 1.3M Q2 '26: 1.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income TTM

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '21: -1.5M Q4 '21: -1.2M Q1 '22: -4.1M Q2 '22: -5M Q3 '22: -5.3M Q4 '22: -6.9M Q1 '23: -5.9M Q2 '23: -5.3M Q3 '23: -5.9M Q4 '23: -3.9M Q1 '24: -2.9M Q2 '24: -2.9M Q3 '24: -2.9M Q4 '24: -3.2M Q1 '25: -3.5M Q2 '25: -4.3M Q3 '25: 103K Q4 '25: 3.4M Q1 '26: 3.4M Q2 '26: 4.1M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue TTM

0 6M 12M 18M Q2 '26: 17.6M Q2 '26

Operating Cash Flow TTM

-4M -2M 0 2M 4M 6M Q3 '21: 4.5M Q4 '21: 4.9M Q1 '22: 965K Q2 '22: -291K Q3 '22: -1.4M Q4 '22: -3.6M Q1 '23: 580K Q2 '23: 2.2M Q3 '23: 2M Q4 '23: 3.7M Q1 '24: 1.7M Q2 '24: 1.9M Q3 '24: 1.2M Q4 '24: 1.9M Q1 '25: 1.6M Q2 '25: 1.6M Q3 '25: -41K Q4 '25: -2.3M Q1 '26: -3.4M Q2 '26: -2.6M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow TTM

-6M -4M -2M 0 2M 4M 6M Q3 '21: 4.1M Q4 '21: 4.8M Q1 '22: 795K Q2 '22: -492K Q3 '22: -1.6M Q4 '22: -3.9M Q1 '23: 377K Q2 '23: 1.2M Q3 '23: 1M Q4 '23: 2.8M Q1 '24: 701K Q2 '24: 1.4M Q3 '24: 770K Q4 '24: 1.4M Q1 '25: 1M Q2 '25: 1.2M Q3 '25: -784K Q4 '25: -3.1M Q1 '26: -4.6M Q2 '26: -3.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 1.5M 3M 4.5M Q2 '19: 1.7M Q3 '19: 1.7M Q1 '20: 1.7M Q1 '21: 1.7M Q2 '21: 1.7M Q3 '21: 1.8M Q1 '22: 1.8M Q2 '22: 1.8M Q3 '22: 1.8M Q1 '23: 1.9M Q2 '23: 1.9M Q3 '23: 1.9M Q1 '24: 1.8M Q2 '24: 1.8K Q3 '24: 1.9K Q1 '25: 2M Q2 '25: 2.1M Q3 '25: 3.1K Q1 '26: 3.9M Q2 '26: 3.9M Q3 '19 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-15.00 -10.00 -5.00 0.00 5.00 10.00 15.00 Q4 '12: -0.51 Q1 '13: -0.52 Q2 '13: -0.98 Q3 '13: -0.70 Q4 '13: -0.94 Q1 '14: -0.92 Q2 '14: -0.64 Q3 '14: -0.83 Q4 '14: -0.91 Q1 '15: -1.02 Q2 '15: -1.16 Q3 '15: -1.26 Q4 '15: -1.46 Q1 '16: -1.36 Q2 '16: -1.37 Q3 '16: -1.24 Q4 '16: -0.74 Q1 '17: -0.69 Q3 '18: -14.43 Q4 '18: -11.86 Q1 '13 Q4 '13 Q3 '14 Q2 '15 Q1 '16 Q4 '16 Q4 '18

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.